Edition:
India

Antares Pharma Inc (ATRS.OQ)

ATRS.OQ on NASDAQ Stock Exchange Capital Market

1.84USD
2:29am IST
Change (% chg)

$-0.05 (-2.65%)
Prev Close
$1.89
Open
$1.88
Day's High
$1.90
Day's Low
$1.83
Volume
186,394
Avg. Vol
405,367
52-wk High
$4.09
52-wk Low
$1.59

Select another date:

Tue, Nov 7 2017

BRIEF-Antares Pharma Q3 loss per share $0.03

* Antares Pharma reports third quarter 2017 operating and financial results

BRIEF-Antares Pharma receives complete response letter from FDA for Xyosted

* Antares pharma receives complete response letter from the fda for Xyosted

BRIEF-Antares Pharma ‍says received FDA letter regarding deficiencies of its drug Xyosted

* Antares Pharma Inc - ‍anticipate receiving further clarification from FDA on or before prescription drug user fee act (PDUFA) date of October 20, 2017​

BRIEF-Antares Pharma announces sale of Zomajet™ needle-free delivery system to Ferring Pharmaceuticals

* Antares Pharma announces sale of Zomajet™ needle-free delivery system to Ferring Pharmaceuticals

BRIEF-Antares Pharma entered sales agreement with cowen and co to offer, sell shares of its common stock, par value $0.01/share- SEC Filing

* Antares Pharma-on Aug 11,entered sales agreement with Cowen and Company under which co may offer, sell shares of its common stock,par value $0.01/share

BRIEF-Antares Pharma Q2 loss per share $0.02

* Antares pharma reports second quarter 2017 operating and financial results

BRIEF-Antares Pharma announces debt financing from Hercules Capital

* Antares Pharma announces debt financing from Hercules Capital

Select another date: